Clinical diagnostic criteria for dementia associated with Parkinson’s disease

Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease

Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240

The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia

Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A., & Gornbein, J. (1994) · Neurology · doi:10.1212/wnl.44.12.2308 · Cited by 7,568

Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium

McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069

α-Synuclein Locus Triplication Causes Parkinson's Disease

Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383

The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia

Zarranz, J. J., Alegre, J., Gómez‐Esteban, J. C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atarés, B., et al. (2004) · Annals of Neurology · doi:10.1002/ana.10795 · Cited by 2,737

A systematic review of prevalence studies of dementia in Parkinson's disease

Aarsland, D., ZACCAI, J. H., & Brayne, C. (2005) · Movement Disorders · doi:10.1002/mds.20527 · Cited by 1,714

Prevalence and Characteristics of Dementia in Parkinson Disease

Aarsland, D., Andersen, K., Larsen, J. O., & Lolk, A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.3.387 · Cited by 1,403

Rivastigmine for Dementia Associated with Parkinson's Disease

Emre, M., Aarsland, D., Albanese, A., Byrne, E. J., Deuschl, G., Deyn, P. P. D., Durif, F., Kulisevsky, J., van Laar, T., Lees, A. J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041470 · Cited by 1,219

Sydney multicenter study of Parkinson's disease: Non‐L‐dopa–responsive problems dominate at 15 years

Hely, M. A., Morris, J. G. L., Reid, W. G. J., & Trafficante, R. (2005) · Movement Disorders · doi:10.1002/mds.20324 · Cited by 1,050

Hallucinations in Parkinson's disease: Prevalence, phenomenology and risk factors

Fénelon, G. (2000) · Brain · doi:10.1093/brain/123.4.733 · Cited by 1,035

Dysfunction of the locus coeruleus–norepinephrine system and related circuitry in Parkinson's disease-related dementia

Tredici, K. D., & Braak, H. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-301817 · Cited by 251

Parkinson's disease dementia: Definitions, guidelines, and research perspectives in diagnosis

Goetz, C. G., Emre, M., & Dubois, B. (2009) · Annals of Neurology · doi:10.1002/ana.21455 · Cited by 232

Decision-making cognition in neurodegenerative diseases

Gleichgerrcht, E. L., Ibáñez, A. M., Roca, M., Torralva, T., & Manes, F. F. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.148 · Cited by 245

Global scales for cognitive screening in Parkinson's disease: Critique and recommendations

Škorvánek, M., Goldman, J. G., Jahanshahi, M., Marras, C., Rektorová, I., Schmand, B. A., van Duijn, E., Goetz, C. G., Weintraub, D. A., Stebbins, G. T., et al. (2017) · Movement Disorders · doi:10.1002/mds.27233 · Cited by 231

Levels of plasma neurofilament light chain and cognitive function in patients with Alzheimer or Parkinson disease

Lin, Y.-S., Lee, W.-J., Wang, S.-J., & Fuh, J.-L. (2018) · Scientific Reports · doi:10.1038/s41598-018-35766-w · Cited by 251

Tau Positron Emission Tomographic Imaging in the Lewy Body Diseases

Gomperts, S. N., Locascio, J. J., Makaretz, S. J., Schultz, A. P., Caso, C., Vasdev, N., Sperling, R. A., Growdon, J. H., Dickerson, B. C., & Johnson, K. A. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.3338 · Cited by 228

Neuropathologically mixed Alzheimer’s and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes

Walker, L., McAleese, K. E., Thomas, A. J., Johnson, M. A., Martin-Ruiz, C. M., Parker, C., Colloby, S. J., Jellinger, K. A., & Attems, J. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1406-3 · Cited by 224

CSF amyloid- and tau proteins, and cognitive performance, in early and untreated Parkinson's Disease: the Norwegian ParkWest study

Alves, G. W., Brønnick, K., Aarsland, D., Blennow, K., Zetterberg, H., Ballard, C. G., Kurz, M. W., Andréasson, U., Tysnes, O., Larsen, J. O., et al. (2010) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.199950 · Cited by 221

Assessment of cortical degeneration in patients with Parkinson's disease by voxel‐based morphometry, cortical folding, and cortical thickness

Pereira, J. B., Ibarretxe‐Bilbao, N., Martı́, M. J., Compta, Y., Junqué, C., Bargalló, N., & TOLOSA, E. S. (2011) · Human Brain Mapping · doi:10.1002/hbm.21378 · Cited by 234

The Prevalence and Incidence of Dementia with Lewy Bodies: a Systematic Review

Hogan, D. B., Fiest, K. M., Roberts, J. I., Maxwell, C. J., Dykeman, J., Pringsheim, T. M., Steeves, T. D. L., Smith, E. E., Pearson, D. M., & Jetté, N. (2016) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2016.2 · Cited by 221

Mild cognitive impairment is linked with faster rate of cortical thinning in patients with Parkinson’s disease longitudinally

Hanganu, A., Bedetti, C., Degroot, C., Mejia‐Constain, B., Lafontaine, A., Soland, V., Chouinard, S., Bruneau, M., Mellah, S., Belleville, S., et al. (2014) · Brain · doi:10.1093/brain/awu036 · Cited by 223

CD4 + T cells contribute to neurodegeneration in Lewy body dementia

Gate, D., Tapp, E., Leventhal, O., Shahid, M., Nonninger, T. J., Yang, A. C., Strempfl, K., Unger, M. S., Fehlmann, T., Oh, H. S., et al. (2021) · Science · doi:10.1126/science.abf7266 · Cited by 215

Mild Cognitive Impairment in Parkinson’s Disease

Aarsland, D., Brønnick, K., & Fladby, T. (2011) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-011-0203-1 · Cited by 213

APOE ε4 is associated with severity of Lewy body pathology independent of Alzheimer pathology

Dickson, D. W., Heckman, M. G., Murray, M. E., Soto, A. I., Walton, R. L., Diehl, N. N., van Gerpen, J. A., Uitti, R. J., Wszolek, Z. K., Ertekin-Taner, N., et al. (2018) · Neurology · doi:10.1212/wnl.0000000000006212 · Cited by 210

Blood NfL

Lin, C., Li, C., Yang, K., Lin, F., Wu, C., Chieh, J.-J., & Chiu, M. (2019) · Neurology · doi:10.1212/wnl.0000000000008088 · Cited by 209

Frequency and Case Identification of Dementia with Lewy Bodies Using the Revised Consensus Criteria

Aarsland, D., Rongve, A., Nore, S. P., Skogseth, R. E., Skulstad, S., Ehrt, U., Hoprekstad, D., & Ballard, C. G. (2008) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000165917 · Cited by 209

Visual symptoms in Parkinson's disease and Parkinson's disease dementia

Archibald, N. K., Clarke, M. P., Mosimann, U. P., & Burn, D. J. (2011) · Movement Disorders · doi:10.1002/mds.23891 · Cited by 220

Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson’s disease with dementia and dementia with Lewy bodies compared to Alzheimer’s disease

Hansson, O., Hall, S., Öhrfelt, A., Zetterberg, H., Blennow, K., Minthon, L., Nägga, K., Londos, E., Varghese, S., Majbour, N. K., et al. (2014) · Alzheimer s Research & Therapy · doi:10.1186/alzrt255 · Cited by 214

Dopaminergic, serotonergic, and noradrenergic deficits in Parkinson disease

Buddhala, C., Loftin, S. K., Kuley, B. M., Cairns, N. J., Campbell, M. C., Perlmutter, J. S., & Kotzbauer, P. T. (2015) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.246 · Cited by 206

Cognitive decline and quality of life in incident Parkinson's disease: The role of attention

Lawson, R. A., Yarnall, A. J., Duncan, G. W., Breen, D. P., Khoo, T. K., Williams‐Gray, C. H., Barker, R. A., Collerton, D., Taylor, J., & Burn, D. J. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.04.009 · Cited by 210

Beyond nine years of continuous subthalamic nucleus deep brain stimulation in Parkinson's disease

Zibetti, M., Merola, A., Rizzi, L., Ricchi, V., Angrisano, S., Azzaro, C., Artusi, C., Arduino, N., Marchisio, A., Lanotte, M., et al. (2011) · Movement Disorders · doi:10.1002/mds.23903 · Cited by 212

Cognitive status correlates with white matter alteration in Parkinson's disease

Hattori, T., Orimo, S., Aoki, S., Ito, K., Abe, O., Amano, A., Sato, R., Sakai, K., & Mizusawa, H. (2011) · Human Brain Mapping · doi:10.1002/hbm.21245 · Cited by 201

Neuropathology of dementia in patients with Parkinson’s disease: a systematic review of autopsy studies

Smith, C., Malek, N., Grosset, K. A., Cullen, B., Gentleman, S., & Grosset, D. G. (2019) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2019-321111 · Cited by 213

Evolution of mild cognitive impairment in Parkinson disease

Broeders, M., de Bie, R. M. A., Velseboer, D. C., Speelman, J. D., Muslimović, D., & Schmand, B. A. (2013) · Neurology · doi:10.1212/wnl.0b013e31829c5c86 · Cited by 201

Resting-state fMRI in Parkinson's disease patients with cognitive impairment: A meta-analysis

Wolters, A. F., van de Weijer, S. C. F., Leentjens, A. F. G., Duits, A., Jacobs, H. I. L., & Kuijf, M. L. (2018) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2018.12.016 · Cited by 214

Rivastigmine in apathetic but dementia and depression-free patients with Parkinson's disease: a double-blind, placebo-controlled, randomised clinical trial

Devos, D., Moreau, C., Maltête, D., Lefaucheur, R., Kreisler, A., Eusébio, A., Defer, G. L., Ouk, T., Azulay, J.-P., Krystkowiak, P. C., et al. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-306439 · Cited by 199

Idiopathic REM sleep behaviour disorder in the development of Parkinson's disease

Boeve, B. F. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70054-1 · Cited by 211

Incidental Lewy Body Disease and Preclinical Parkinson Disease

DelleDonne, A., Klos, K. J., Fujishiro, H., Ahmed, Z., Parisi, J. E., Josephs, K. A., Frigerio, R., Burnett, M. S., Wszołek, Z. K., Uitti, R. J., et al. (2008) · Archives of Neurology · doi:10.1001/archneur.65.8.1074 · Cited by 197

Cerebrospinal Fluid Patterns and the Risk of Future Dementia in Early, Incident Parkinson Disease

Bäckström, D. C., Domellöf, M. E., Linder, J., Olsson, B., Öhrfelt, A., Trupp, M., Zetterberg, H., Blennow, K., & Forsgren, L. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2015.1449 · Cited by 200

Milestones in Parkinson's disease—Clinical and pathologic features

Halliday, G. M., Lees, A. J., & Stern, M. (2011) · Movement Disorders · doi:10.1002/mds.23669 · Cited by 218

Regional Multiple Pathology Scores Are Associated with Cognitive Decline in L ewy Body Dementias

Howlett, D. R., Whitfield, D., Johnson, M. A., Attems, J., O'Brien, J. T., Aarsland, D., Lai, M. K. P., Lee, J. H., Chen, C., Ballard, C. G., et al. (2014) · Brain Pathology · doi:10.1111/bpa.12182 · Cited by 199

Predictors of cognitive impairment in an early stage Parkinson's disease cohort

Hu, M. T. M., Szewczyk‐Królikowski, K., Tomlinson, P. R., Nithi, K. A., Rolinski, M., Murray, C., Talbot, K., Ebmeier, K. P., Mackay, C. E., & Ben‐Shlomo, Y. (2014) · Movement Disorders · doi:10.1002/mds.25748 · Cited by 206

Long-term outcome of subthalamic nucleus DBS in Parkinson's disease: From the advanced phase towards the late stage of the disease?

Rizzone, M. G., Fasano, A. A., Daniele, A., Zibetti, M., Merola, A., Rizzi, L., Piano, C., Piccininni, C., Romito, L. M., Lopiano, L., et al. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.01.012 · Cited by 193

The Diagnosis of Delirium Superimposed on Dementia: An Emerging Challenge

Morandi, A., Davis, D. H. J., Bellelli, G., Arora, R. C., Caplan, G. A., Kamholz, B. A., Kolanowski, A. M., Fick, D. M., Kreisel, S. H., MacLullich, A. M. J., et al. (2016) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2016.07.014 · Cited by 192

Mild cognitive impairment is common in Parkinson's disease patients with normal Mini-Mental State Examination (MMSE) scores

Mamikonyan, E., Moberg, P. J., Siderowf, A., Duda, J. E., Have, T. T., Hurtig, H. I., Stern, M. B., & Weintraub, D. (2009) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.05.006 · Cited by 192

Resting-state functional connectivity associated with mild cognitive impairment in Parkinson’s disease

Amboni, M., Tessitore, A., Esposito, F., Santangelo, G., Picillo, M., Vitale, C., Giordano, A., Erro, R., Micco, R. D., Corbo, D., et al. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7591-5 · Cited by 201

Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial

Moreau, C., Delval, A., Defebvre, L., Dujardin, K., Duhamel, A., Petyt, G., Vuillaume, I., Corvol, J., Brefel‐Courbon, C., Ory‐Magne, F., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70106-0 · Cited by 191

Differential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer’s disease, frontotemporal dementia and progressive supranuclear palsy

Chouliaras, L., Thomas, A., Malpetti, M., Donaghy, P., Kane, J., Mak, E., Savulich, G., Prats-Sedano, M. A., Heslegrave, A. J., Zetterberg, H., et al. (2022) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2021-327788 · Cited by 199

Neuroinflammation and protein pathology in Parkinson’s disease dementia

Kouli, A., Camacho, M., Allinson, K. S. J., & Williams‐Gray, C. H. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01083-5 · Cited by 196

Serum Brain-Derived Neurotrophic Factor Levels in Different Neurological Diseases

Ventriglia, M., Zanardini, R., Bonomini, C., Zanetti, O., Volpe, D., Pasqualetti, P., Gennarelli, M., & Bocchio-Chiavetto, L. (2013) · BioMed Research International · doi:10.1155/2013/901082 · Cited by 189

Cognitive impairment in Parkinson's disease: Tools for diagnosis and assessment

Kulisevsky, J., & Pagonabarraga, J. (2009) · Movement Disorders · doi:10.1002/mds.22506 · Cited by 188

A recommended scale for cognitive screening in clinical trials of Parkinson's disease

Chou, K. L., Amick, M. M., Brandt, J., Camicioli, R. M., Frei, K. P., Gitelman, D. R., Goldman, J. G., Growdon, J. H., Hurtig, H. I., Levin, B. E., et al. (2010) · Movement Disorders · doi:10.1002/mds.23362 · Cited by 186

Neuropathological correlates of dopaminergic imaging in Alzheimer's disease and Lewy body dementias

Colloby, S. J., McParland, S., O'Brien, J. T., & Attems, J. (2012) · Brain · doi:10.1093/brain/aws211 · Cited by 188

Gait improvement via rhythmic stimulation in Parkinson’s disease is linked to rhythmic skills

Bella, S. D., Benoit, C.-É., Farrugia, N., Keller, P. E., Obrig, H., Mainka, S., & Kotz, S. A. (2017) · Scientific Reports · doi:10.1038/srep42005 · Cited by 187

Cognitive impairment in Parkinson’s disease: a report from a multidisciplinary symposium on unmet needs and future directions to maintain cognitive health

Goldman, J. G., Vernaleo, B. A., Camicioli, R. M., Dahodwala, N. A., Dobkin, R. D., Ellis, T. D., Galvin, J. E., Marras, C., Edwards, J. D., Fields, J. A., et al. (2018) · npj Parkinson s Disease · doi:10.1038/s41531-018-0055-3 · Cited by 188

An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders

Ashton, N. J., Hye, A., Rajkumar, A. P., Leuzy, A., Snowden, S. G., Suárez‐Calvet, M., Karikari, T. K., Schöll, M., Joie, R. L., Rabinovici, G. D., et al. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0348-0 · Cited by 185

Cerebrospinal tau, phospho‐tau, and beta‐amyloid and neuropsychological functions in Parkinson's disease

Compta, Y., Martı́, M. J., Ibarretxe‐Bilbao, N., Junqué, C., Valldeoriola, F., Muñoz, E., Ezquerra, M., Ríos, J., & TOLOSA, E. S. (2009) · Movement Disorders · doi:10.1002/mds.22594 · Cited by 185

Profile of Cognitive Impairment in Parkinson's Disease

Watson, G. S., & Leverenz, J. B. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2010.00373.x · Cited by 203

Gait variability across neurodegenerative and cognitive disorders: Results from the Canadian Consortium of Neurodegeneration in Aging (CCNA) and the Gait and Brain Study

Pieruccini‐Faria, F., Black, S. E., Masellis, M., Smith, E. E., Almeida, Q. J., Li, K., Bherer, L., Camicioli, R. M., & Montero‐Odasso, M. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12298 · Cited by 198

Pathological α-synuclein distribution in subjects with coincident Alzheimer’s and Lewy body pathology

Toledo, J. B., Gopal, P., Raible, K., Irwin, D. J., Brettschneider, J., Sedor, S., Waits, K., Boluda, S., Grossman, M., Van Deerlin, V. M., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-015-1526-9 · Cited by 184

CSF biomarkers cutoffs: The importance of coincident neuropathological diseases

Toledo, J. B., Brettschneider, J., Grossman, M., Arnold, S. E., Hu, W. T., Xie, S. X., Lee, V. M.-Y., Shaw, L. M., & Trojanowski, J. Q. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0983-7 · Cited by 182

Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia

Gomperts, S. N., Locascio, J. J., Rentz, D. M., Santarlasci, A., Marquié, M., Johnson, K. A., & Growdon, J. H. (2012) · Neurology · doi:10.1212/wnl.0b013e31827b1a07 · Cited by 189

Visual spatial cognition in neurodegenerative disease

Possin, K. L. (2010) · Neurocase · doi:10.1080/13554791003730600 · Cited by 204

Nonmotor and diagnostic findings in subjects with de novo Parkinson disease of the DeNoPa cohort

Mollenhauer, B., Trautmann, E., Sixel‐Döring, F., Wicke, T., Ebentheuer, J., Schaumburg, M., Lang, E., Focke, N. K., Kumar, K. R., Lohmann, K., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e3182a6cbd5 · Cited by 185

CSF Aβ42 and tau in Parkinson's disease with cognitive impairment

Montine, T. J., Shi, M. Y., Quinn, J. F., Peskind, E. R., Craft, S., Ginghină, C., Chung, K. A., Kim, H., Galasko, D. R., Jankovic, J. J., et al. (2010) · Movement Disorders · doi:10.1002/mds.23287 · Cited by 185

Retinal Nerve Fiber Layer Thinning in Dementia Associated with Parkinson's Disease, Dementia with Lewy Bodies, and Alzheimer's Disease

Moreno‐Ramos, T., Benito‐León, J., Villarejo‐Galende, A., & Bermejo‐Pareja, F. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121975 · Cited by 181

Epidemiology of aging and associated cognitive disorders: Prevalence and incidence of Alzheimer's disease and other dementias

López, O. L., & Kuller, L. H. (2019) · Handbook of clinical neurology · doi:10.1016/b978-0-12-804766-8.00009-1 · Cited by 196

Neuropathobiology of non-motor symptoms in Parkinson disease

Jellinger, K. A. (2015) · Journal of Neural Transmission · doi:10.1007/s00702-015-1405-5 · Cited by 186

Levodopa unresponsive symptoms in Parkinson disease

Sethi, K. D. (2008) · Movement Disorders · doi:10.1002/mds.22049 · Cited by 177

SveDem, the Swedish Dementia Registry – A Tool for Improving the Quality of Diagnostics, Treatment and Care of Dementia Patients in Clinical Practice

Religa, D., Fereshtehnejad, S., Čermáková, P., Edlund, A., Ptacek, S. G., Granqvist, N., Hallbäck, A., Kåwe, K., Farahmand, B. Y., Kilander, L., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0116538 · Cited by 185

Incidental Lewy body disease: Do some cases represent a preclinical stage of dementia with Lewy bodies?

Frigerio, R., Fujishiro, H., Ahn, T. B., Josephs, K. A., Maraganore, D. M., DelleDonne, A., Parisi, J. E., Klos, K. J., Boeve, B. F., Dickson, D. W., et al. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.05.019 · Cited by 172

Early predictors of mortality in parkinsonism and Parkinson disease

Bäckström, D. C., Granåsen, G., Domellöf, M., Linder, J., Mo, S. J., Riklund, K., Zetterberg, H., Blennow, K., & Forsgren, L. (2018) · Neurology · doi:10.1212/wnl.0000000000006576 · Cited by 188

Functional brain activity and presynaptic dopamine uptake in patients with Parkinson's disease and mild cognitive impairment: a cross-sectional study

Ekman, U., Eriksson, J., Forsgren, L., Mo, S. J., Riklund, K., & Nyberg, L. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70138-2 · Cited by 172

Cognitive Impairment and Dementia in Parkinson’s Disease: Clinical Features, Diagnosis, and Management

Meireles, J., & Massano, J. (2012) · Frontiers in Neurology · doi:10.3389/fneur.2012.00088 · Cited by 181

Neuropsychological Characteristics of Dementia with Lewy Bodies and Parkinson’s Disease with Dementia: Differentiation, Early Detection, and Implications for “Mild Cognitive Impairment” and Biomarkers

Tröster, A. I. (2008) · Neuropsychology Review · doi:10.1007/s11065-008-9055-0 · Cited by 173

Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson Disease

Aamodt, W. W., Waligórska, T., Shen, J., Tropea, T. F., Siderowf, A. D., Weintraub, D. A., Grossman, M., Irwin, D. J., Wolk, D. A., Xie, S. X., et al. (2021) · Movement Disorders · doi:10.1002/mds.28779 · Cited by 179

The influence of cognitive impairment on health-related quality of life in neurological disease

Mitchell, A. J., Kemp, S., Benito‐León, J., & Reuber, M. (2010) · Acta Neuropsychiatrica · doi:10.1111/j.1601-5215.2009.00439.x · Cited by 185

Mortality Risk after Dementia Diagnosis by Dementia Type and Underlying Factors: A Cohort of 15,209 Patients based on the Swedish Dementia Registry

Garcia-Ptacek, S., Farahmand, B., Kåreholt, I., Religa, D., Cuadrado, M. L., & Eriksdotter, M. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-131856 · Cited by 176

Modulation of verbal fluency networks by transcranial direct current stimulation (tDCS) in Parkinson’s disease

Pereira, J. B., Junqué, C., David Bartrés-faz, A., Martı́, M. J., Sala‐Llonch, R., Compta, Y., Falcón, C., Vendrell, P., Pascual‐Leone, Á., Valls‐Solé, J., et al. (2012) · Brain stimulation · doi:10.1016/j.brs.2012.01.006 · Cited by 171

Brain amyloid and cognition in Lewy body diseases

Gomperts, S. N., Locascio, J. J., Marquié, M., Santarlasci, A., Rentz, D. M., Maye, J. E., Johnson, K. A., & Growdon, J. H. (2012) · Movement Disorders · doi:10.1002/mds.25048 · Cited by 171

Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseases

Sheinerman, K. S., Toledo, J. B., Tsivinsky, V. G., Irwin, D., Grossman, M., Weintraub, D., Hurtig, H. I., Chen-Plotkin, A., Wolk, D. A., McCluskey, L. F., et al. (2017) · Alzheimer's Research & Therapy · doi:10.1186/s13195-017-0316-0 · Cited by 154

Carer burden in apathy and impulse control disorders in Parkinson's disease

Leroi, I., Harbishettar, V., Andrews, M., McDonald, K. R., Byrne, E. J., & Burns, A. S. (2011) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2704 · Cited by 166

L ongitudinal M easurements of C erebrospinal F luid B iomarkers in P arkinson's D isease

Hall, S., Surova, Y., Öhrfelt, A., Study, T. S. B., Blennow, K., Zetterberg, H., & Hansson, O. (2016) · Movement Disorders · doi:10.1002/mds.26578 · Cited by 165

In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia

Burack, M. A., Hartlein, J. M., Flores, H., Taylor-Reinwald, L., Perlmutter, J. S., & Cairns, N. J. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c7da8e · Cited by 165

The Contribution of Tau, Amyloid-Beta and Alpha-Synuclein Pathology to Dementia in Lewy Body Disorders

Irwin, D. J., & Hurtig, H. I. (2018) · Journal of Alzheimer’s Disease & Parkinsonism · doi:10.4172/2161-0460.1000444 · Cited by 177

Grey matter hypometabolism and atrophy in Parkinson’s disease with cognitive impairment: a two-step process

Gonzalez-Redondo, R., García‐García, D., Clavero, P., Gasca‐Salas, C., de Eulate, M. R. G., Zubieta, J. L., Arbizu, J., Obeso, J. A., & Rodríguez‐Oroz, M. (2014) · Brain · doi:10.1093/brain/awu159 · Cited by 163

Blind randomized controlled study of the efficacy of cognitive training in Parkinson's disease

Prats, A., Saleta, H. G., Crespo, M. C., Silvestre, E., Garolera, M., Torrellas, C. P., Pont, S. A., Nadal, M. F., Garcia, S. A., Bartolomé, M. V. P., et al. (2011) · Movement Disorders · doi:10.1002/mds.23688 · Cited by 174

The Neuropsychiatry of Parkinson Disease: A Perfect Storm

Weintraub, D. A., & Mamikonyan, E. (2019) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2019.03.002 · Cited by 172

Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology

O'Brien, J. T., & Burns, A. S. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881110387547 · Cited by 166

Behavioral and Psychological Symptoms of Dementia in Different Dementia Disorders: A Large-Scale Study of 10,000 Individuals

Schwertner, E., Pereira, J. B., Xu, H., Sečník, J., Winblad, B. G., Eriksdotter, M., Nägga, K., & Religa, D. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215198 · Cited by 162

Acetylcholine bidirectionally regulates learning and memory

Huang, Q., Liao, C., Ge, F., Ao, J., & Liu, T. (2022) · Journal of Neurorestoratology · doi:10.1016/j.jnrt.2022.100002 · Cited by 181

Concomitant pathologies among a spectrum of parkinsonian disorders

Dugger, B. N., Adler, C. H., Shill, H. A., Caviness, J. N., Jacobson, S. A., Driver‐Dunckley, E. D., & Beach, T. G. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.02.012 · Cited by 172

Dementia is associated with Insulin Resistance in patients with Parkinson's Disease

Bosco, D., Plastino, M., Cristiano, D., Colica, C., Ermio, C., Bartolo, M. D., Mungari, P., Fonte, G., Consoli, D., Consoli, A., et al. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.12.008 · Cited by 160

The major impact of freezing of gait on quality of life in Parkinson’s disease

Walton, C. C., Shine, J. M., Hall, J. M., O’Callaghan, C., Mowszowski, L., Gilat, M., Szeto, J. Y. Y., Naismith, S. L., & Lewis, S. J. G. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7524-3 · Cited by 173

Combined dementia-risk biomarkers in Parkinson's disease: A prospective longitudinal study

Compta, Y., Pereira, J. B., Ríos, J., Ibarretxe‐Bilbao, N., Junqué, C., Bargalló, N., Cámara, A., Buongiorno, M., Fernández, M., Pont‐Sunyer, C., et al. (2013) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2013.03.009 · Cited by 163

Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease

Caspell‐Garcia, C., Simuni, T., Tosun, D., Wu, I.-W., Zhang, Y., Nalls, M. A., Singleton, A., Shaw, L. M. J., Kang, J., Trojanowski, J. Q., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175674 · Cited by 155

White matter microstructure deteriorates across cognitive stages in Parkinson disease

Melzer, T. R., Watts, R., MacAskill, M. R., Pitcher, T. L., Livingston, L., Keenan, R. J., Dalrymple‐Alford, J. C., & Anderson, T. (2013) · Neurology · doi:10.1212/wnl.0b013e3182929f62 · Cited by 163

Vascular disease and vascular risk factors in relation to motor features and cognition in early Parkinson's disease

Malek, N., Lawton, M., Swallow, D. M. A., Grosset, K. A., Marrinan, S. L., Bajaj, N. P. S., Barker, R. A., Burn, D. J., Hardy, J., Morris, H. R., et al. (2016) · Movement Disorders · doi:10.1002/mds.26698 · Cited by 158

Lewy body dementia: The caregiver experience of clinical care

Galvin, J. E., Duda, J. E., Kaufer, D., Lippa, C. F., Taylor, A., & Zarit, S. H. (2010) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2010.03.007 · Cited by 157

Mild cognitive impairment as a risk factor for Parkinson's disease dementia

Hoogland, J., Boel, J. A., de Bie, R. M. A., Geskus, R. B., Schmand, B. A., Dalrymple‐Alford, J. C., Marras, C., Adler, C. H., Goldman, J. G., Tröster, A. I., et al. (2017) · Movement Disorders · doi:10.1002/mds.27002 · Cited by 171

CSF Aβ 42 predicts early-onset dementia in Parkinson disease

Alves, G. W., Lange, J., Blennow, K., Zetterberg, H., Andréasson, U., Førland, M. G. G., Tysnes, O., Larsen, J. O., & Pedersen, K. F. (2014) · Neurology · doi:10.1212/wnl.0000000000000425 · Cited by 158

Incidence of and risk factors for cognitive impairment in an early Parkinson disease clinical trial cohort

Uc, E. Y., McDermott, M., Marder, K. S., Anderson, S. W., Litvan, I., Como, P. G., Auinger, P., Chou, K. L., & Growdon, J. H. (2009) · Neurology · doi:10.1212/wnl.0b013e3181bf992f · Cited by 154

Cognitive decline in Parkinson’s disease: A prospective longitudinal study

Muslimović, D., Post, B., Speelman, J. D., de Haan, R. J., & Schmand, B. A. (2009) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617709090614 · Cited by 164

Cerebrospinal fluid concentrations of inflammatory markers in Parkinson’s disease and atypical parkinsonian disorders

Hall, S., Janelidze, S., Surova, Y., Widner, H., Zetterberg, H., & Hansson, O. (2018) · Scientific Reports · doi:10.1038/s41598-018-31517-z · Cited by 157

Plasma α-synuclein predicts cognitive decline in Parkinson’s disease

Lin, C., Yang, S., Horng, H. E., Yang, C., Chieh, J.-J., Chen, H.-H., Liu, B.-H., & Chiu, M. (2017) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2016-314857 · Cited by 158

Association between cognition and function in patients with Parkinson disease with and without dementia

Rosenthal, E. W., Brennan, L., Xie, S. X., Hurtig, H. I., Milber, J. M., Weintraub, D. A., Karlawish, J. H., & Siderowf, A. D. (2010) · Movement Disorders · doi:10.1002/mds.23073 · Cited by 153

Distribution and Load of Amyloid-β Pathology in Parkinson Disease and Dementia with Lewy Bodies

Hepp, D. H., Vergoossen, D. L. E., Huisman, E., Lemstra, A. W., Bank, N. B., Berendse, H. W., Rozemüller, A. J. M., Foncke, E. M. J., & van de Berg, W. D. J. (2016) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlw070 · Cited by 159

Dementia in Parkinson's disease

Hanagasi, H. A., Tüfekçıoğlu, Z., & Emre, M. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.01.012 · Cited by 156

Mild cognitive impairment in Parkinson's disease.

Goldman, J. G., & Litvan, I. (2011) · PubMed · Cited by 152

Development of excessive daytime sleepiness in early Parkinson disease

Tholfsen, L. K., Larsen, J. O., Schulz, J., Tysnes, O., & Gjerstad, M. D. (2015) · Neurology · doi:10.1212/wnl.0000000000001737 · Cited by 152

Dementia in Parkinson's Disease

Burn, D. J. (2009) · Blue books of neurology · doi:10.1016/b978-1-4160-6641-5.00012-x · Cited by 17

Parkinson's disease dementia: Definitions, guidelines, and research perspectives in diagnosis

Goetz, C. G., Emre, M., & Dubois, B. (2009) · Annals of Neurology · doi:10.1002/ana.21455 · Cited by 232

Diagnosis and Treatment of Parkinson's Disease Dementia : An Update

Park, M. Y. (2007) · Journal of Yeungnam Medical Science · doi:10.12701/yujm.2007.24.2s.s159

Clinical phenotype of Parkinson disease dementia

Galvin, J. E., Pollack, J., & Morris, J. C. (2006) · Neurology · doi:10.1212/01.wnl.0000242630.52203.8f · Cited by 264

Dementia associated with Parkinson’s disease: Applying the Movement Disorder Society Task Force criteria

Martínez‐Martín, P., Falup‐Pecurariu, C., Rodríguez‐Blázquez, C., Serrano‐Dueñas, M., Artal, F. J. C., Rojo-Abuín, J. M., & Aarsland, D. (2011) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2011.05.017 · Cited by 64